| Press Releases

Worldwide Clinical Trials to Host Webinar on Current and Future Potential of “Siteless” Clinical Trials

MORRISVILLE, NC, July 7, 2016 – Worldwide Clinical Trials will host a free webinar, titled “Are We Moving Toward ‘Siteless’ Clinical Trials? Exploring the Current and Future Potential of Home-Based Studies,” on Thursday, July 14, 2016 at 11 am ET. Leading the discussion will be Worldwide’s Chief Medical and Scientific Officer, Michael Murphy, M.D., Ph.D.

“Advancements in technology are impacting many aspects of clinical research, opening doors to innovative study designs and clinical operations that may not have been a possibility even five years ago. This is especially true when evaluating the potential impact of emerging technology for home-based assessments envisioned as a component of observational or interventional research,” explained Dr. Murphy. “During our upcoming webinar, we will discuss the implications of ‘siteless’ clinical trials for patients and researchers from the perspective of different stakeholders, highlighting areas  in which there are opportunities and challenges, including adherence to regulatory guidance, assurance of data integrity and site management issues.”

During the presentation, Dr. Murphy will be joined by several of his Worldwide colleagues who will share valuable insights on the topic, including Lorna Graham, associate director of Project Management; Doug Lytle, Ph.D., executive director of Clinical Assessment Technologies; and Barbara Zupancic, director of Global Patient Recruitment and Retention. Webinar attendees will be encouraged to submit questions throughout the presentation, which will be addressed during a question and answer period.

To register for this free Worldwide Clinical Trials webinar, visit: http://go.worldwide.com/2016_Events_Webinar_Siteless_Trials_Webcast_Registration_LP.html

Connect with Worldwide Clinical Trials:

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit www.Worldwide.com.

Recent Press Releases


Our extensive collection of scientific articles and papers